XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation - Stock options (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Options        
Outstanding at beginning of period (in shares) 3,021,799 1,761,062 1,761,062  
Granted (in shares) 1,628,795 1,088,000    
Exercised (in shares) (44,105)      
Cancelled (in shares) (232,987)      
Outstanding at end of period (in shares) 4,373,502 2,849,062 3,021,799 1,761,062
Vested at end of period (in shares) 1,189,491 398,157    
Vested and expected to vest at end of period (in shares) 4,373,502 2,849,062    
Weighted average exercise price        
Outstanding at beginning of period (in dollars per share) $ 3.71 $ 0.95 $ 0.95  
Granted (in dollars per share) 3.06 7.78    
Exercised (in dollars per share) 0.43      
Cancelled (in dollars per share) 4.24      
Outstanding at end of period (in dollars per share) 3.47 3.56 $ 3.71 $ 0.95
Vested at end of period (in dollars per share) 1.95 0.96    
Vested and expected to vest at end of period (in dollars per share) $ 3.47 $ 3.56    
Weighted-average remaining contractual term and Aggregate intrinsic value        
Outstanding at end of period (in years) 8 years 10 months 9 days 9 years 1 month 17 days 8 years 11 months 8 days 9 years 6 months 14 days
Vested at end of period (in years) 8 years 7 months 28 days 8 years 3 months 18 days    
Vested and expected to vest at end of period (in years) 8 years 10 months 9 days 9 years 1 month 17 days    
Outstanding at beginning of period (in dollars) $ 10,903 $ 723 $ 723  
Granted (in dollars)   3,087    
Outstanding at end of period (in dollars) 477 12,056 $ 10,903 $ 723
Vested at end of period (in dollars) 316 2,805    
Vested and expected to vest at end of period (in dollars) $ 477 $ 12,056    
Weighted average grant-date fair value of stock options granted $ 2.04 $ 5.07